Skip to main content

Table 1 Characteristics of study population: 2015–2019

From: Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Australian primary care patients: only part of the story?

 

2015

2016

2017

2018

2019

Number of patients

2,811,876

% (n)

2,939,792

% (n)

3,019,638

% (n)

3,043,918

% (n)

2,991,489

% (n)

Sex % (n):

 Male

44.7 (1,255,682)

44.7 (1,314,191)

44.7 (1,349,991)

44.7 (1,359,649)

44.6 (1,333,521)

 Female

55.3 (1,556,194)

55.3 (1,625,601)

55.3 (1,669,647)

55.3 (1,684,269)

55.4 (1,657,968)

Age groups % (n):

 13–19

9.2 (258,375)

9.1 (268,042)

9.0 (272,853)

8.9 (272,198)

8.8 (263,163)

 20–29

16.8 (473,049)

16.9 (497,340)

16.9 (510,591)

16.8 (512,067)

16.7 (498,436)

 30–39

17.3 (485,354)

17.5 (513,357)

17.6 (531,723)

17.8 (541,850)

17.9 (534,827)

 40–49

16.3 (457,570)

16.1 (472,948)

15.9 (480,509)

15.7 (477,754)

15.5 (462,430)

 50–59

14.9 (419,465)

14.7 (432,341)

14.5 (438,992)

14.4 (437,957)

14.3 (426,778)

 60–69

12.6 (353,291)

12.5 (367,427)

12.4 (375,807)

12.5 (379,266)

12.6 (375,879)

 70–79

7.78 (218,777)

8.0 (235,805)

8.3 (251,259)

8.6 (261,238)

8.9 (267,291)

 80 + 

5.2 (145,995)

5.2 (152,532)

5.2 (157,904)

5.3 (161,588)

5.4 (162,685)

Remoteness indicator: %(n)

 Major City

62.1 (1,745,669)

62.8 (1,845,847)

63.3 (1,912,829)

63.8(1,942,453)

64.2 (1,919,721)

 Inner regional

24.6 (692,835)

24.2 (711,228)

23.8 (719,996)

23.6 (719,387)

23.5 (704,270)

 Outer regional

11.3 (318,701)

11.0 (322,066)

10.7 (324,164)

10.5 (320,768)

10.3 (309,540)

 Remote/very Remote

1.9 (54,671)

2.1 (60,651)

2.1 (62,649)

2.0 (61,310)

1.9 (57,958)

IRSAD quintiles % (n):

 1(most disadvantaged)

16.8 (471,802)

16.4 (481,149)

16.2 (487,922)

16.0 (488,421)

15.8 (473,940)

 2

18.3 (513,368)

18.0 (530,242)

17.9 (540,377)

17.7 (539,537)

17.6 (527,685)

 3

21.5 (604,492)

21.8 (640,833)

22.1 (667,073)

22.5 (677,415)

22.4 (669,526)

 4

19.3 (542,827)

19.8 (582,249)

20.1 (607,076)

20.4 (620,508)

20.7 (618,097)

 5(most advantaged)

24.2 (679,387)

24.0 (705,319)

23.8 (717,190)

23.6 (718,037)

23.5 (702,241)